Skip to main content
. Author manuscript; available in PMC: 2019 Mar 12.
Published in final edited form as: Sci Transl Med. 2014 Dec 3;6(265):265ra167. doi: 10.1126/scitranslmed.3009500

Fig. 2. Radiologic response rates of oxazolidinone-treated animals by treatment group.

Fig. 2.

(A) Volume of “hard” abnormal CT density (−100 to 200 HU) for each animal at baseline (top panel), log2-fold change from baseline to one month (middle panel), log2-fold change from baseline to two months (bottom panel). (B) Total glycolytic activity (TGA) for each animal at baseline (top panel), log2-fold change from baseline to one month (middle panel), log2-fold change from baseline to two months (bottom panel).